Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preventing panic disorder: cost-effectiveness analysis alongside a pragmatic randomised trial.

Filip Smit1,2, Godelief Willemse1, Peter Meulenbeek3

  • 1Centre of Prevention and Early Intervention, Trimbos Institute (Netherlands Institute of Mental Health and Addiction), Utrecht, the Netherlands.

Cost Effectiveness and Resource Allocation : C/E
|April 28, 2009
PubMed
Summary

Related Concept Videos

Panic Disorder01:27

Panic Disorder

Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness of community versus hospital-based mental healthcare for severe mental illness in South-East Europe: economic evaluation of five randomised trials.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
Same author

Cost-utility and cost-effectiveness of SELFIE, a transdiagnostic ecological momentary intervention for improving self-esteem in youth aged 12-26 years exposed to childhood adversity: Findings from a multicenter randomized controlled trial.

Psychological medicine·2026
Same author

Economic benefits of mental well-being over time: Results from the Netherlands mental health survey and incidence study-2.

Public health·2025
Same author

Community versus institutionalised care for people with severe mental illness in five countries in Southeast Europe: pooled analysis of five randomised trials.

BMJ global health·2025
Same author

Emotion regulation as a mediator of dialectical behaviour therapy for autistic adults with suicidal ideation.

Cognitive behaviour therapy·2025
Same author

Cost-effectiveness of dialectical behavioural therapy versus treatment as usual for autism with suicidal behaviours: single-blind randomised controlled trial.

The European journal of health economics : HEPAC : health economics in prevention and care·2025

Preventing panic disorder with cognitive-behavioral therapy may be cost-effective. Early intervention shows promise, especially with minimal therapist time, but larger trials are needed for confirmation.

Area of Science:

  • Psychiatry
  • Health Economics

Background:

  • Panic disorder presents a significant public health challenge with substantial societal costs.
  • Preventive interventions are crucial to reduce the incidence of panic disorder and its associated burdens.
  • This study provides the first economic evaluation of a panic disorder prevention intervention.

Purpose of the Study:

  • To evaluate the cost-effectiveness of a time-limited cognitive-behavioral therapy (CBT) intervention for preventing panic disorder.
  • To compare the economic impact of CBT versus care-as-usual in individuals with panic disorder symptoms.

Main Methods:

  • A randomized trial involving 117 participants with panic disorder symptoms was conducted.
  • Interventions included time-limited CBT and care-as-usual, with the primary outcome being panic disorder-free survival over 3 months.

Related Experiment Videos

  • Cost-effectiveness was assessed from a societal perspective using incremental cost-effectiveness ratios and bootstrap analysis.
  • Main Results:

    • The median incremental cost-effectiveness ratio was €6,198 per panic disorder-free survival gained.
    • The intervention demonstrated a 75.2% likelihood of being more cost-effective than care-as-usual, assuming a willingness-to-pay threshold of €10,000.
    • Therapist time was the primary cost driver; reducing therapist hours improved cost-effectiveness.

    Conclusions:

    • The preventive CBT intervention appears potentially acceptable from a cost-effectiveness standpoint, particularly with minimized therapist involvement.
    • The study's small sample size and short follow-up period necessitate caution in interpreting results.
    • Further research with larger sample sizes and longer follow-up durations is recommended to confirm findings and guide broad implementation.